Publication | Open Access

Donanemab detects a minor fraction of amyloid-β plaques in post-mortem brain tissue of patients with Alzheimer’s disease and Down syndrome

Down SyndromeNeurodegenerative DiseasesAlzheimer's DiseaseAmyloid-β PlaquesNeurochemical BiomarkersNeuroscienceNeurologyNeurodegenerationBrain PathologyNeuropathologyMedicineMinor Fraction